← Back
$REPL All transactions

Replimune Group, Inc.

A

$ Value

$0

Shares

251,240

Price

$0

Filed

Apr 7

Insider

Name

Patel Sushil

Title

Chief Executive Officer

CIK

0001860609

Roles

Director Officer

Transaction Details

Transaction Date

2026-04-01

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

784,816

Footnotes

Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2027 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2030, subject to the Reporting Person's continuous service to the Issuer. | 25% of the shares underlying this stock option vest on April 1, 2027, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.

Filing Info

Accession No.

0001104659-26-040571

Form Type

4

Issuer CIK

0001737953

Patel Sushil's History

Date Ticker Type Value
2026-04-01 REPL A $0
2026-04-01 REPL A $0
2025-06-26 RVMD A $0
2025-06-26 RVMD A $0
2025-05-20 REPL $202K

Other Insiders at REPL (90d)

Insider Bought Sold Last
SLATTERY JOSEPH P 2026-04-01
BAKER BROS. ADVISORS LP 2026-04-01
Astley-Sparke Philip 2026-04-01
Pucci Paolo 2026-04-01
Dhingra Kapil 2026-04-01
Balachandran Madhavan 2026-04-01
Weinand Dieter 2026-04-01
Hill Emily Luisa
Chief Financial Officer
2026-04-01
Oliger Christy J. 2026-04-01
Patel Sushil
Chief Executive Officer
2026-04-01
Xynos Konstantinos
Chief Medical Officer
2026-04-01
Schwendenman Andrew
Chief Accounting Officer
2026-04-01
Peeples-Dyer Veleka 2026-04-01
Sarchi Christopher
Chief Commercial Officer
$52K 2026-04-02